AIM: To assess compliance with Joint National Committee 7 (JNC 7) guidelines and evaluate target blood pressure (BP) goals among patients with hypertension. RESULTS: Basic laboratory workup was completed on 75% of patients, and 71% received smoking cessation counseling. Overall BP goal achievement was 45.6%; it was 27.6% and 21.1% among diabetes and chronic kidney disease (CKD) patients, respectively. An average of 2.6 antihypertensive medications were prescribed per patient, with beta-blockers being the most frequently used, followed by thiazide diuretics and angiotensin-converting enzyme inhibitors (ACEIS). ACEIS or angiotensin receptor blockers (ARBs) were not prescribed for 16% of diabetics, 26% of chronic renal failure patients, or 41% of those with history of stroke. Among heart failure patients, 24.1% were not on ACEI or ARBs, and 20.7% were not receiving beta-blockers. CONCLUSIONS: Certain aspects of JNC 7 are not well incorporated into clinical practice, especially among patients with coexisting diabetes and/or CKD.
AIM: To assess compliance with Joint National Committee 7 (JNC 7) guidelines and evaluate target blood pressure (BP) goals among patients with hypertension. RESULTS: Basic laboratory workup was completed on 75% of patients, and 71% received smoking cessation counseling. Overall BP goal achievement was 45.6%; it was 27.6% and 21.1% among diabetes and chronic kidney disease (CKD) patients, respectively. An average of 2.6 antihypertensive medications were prescribed per patient, with beta-blockers being the most frequently used, followed by thiazide diuretics and angiotensin-converting enzyme inhibitors (ACEIS). ACEIS or angiotensin receptor blockers (ARBs) were not prescribed for 16% of diabetics, 26% of chronic renal failurepatients, or 41% of those with history of stroke. Among heart failurepatients, 24.1% were not on ACEI or ARBs, and 20.7% were not receiving beta-blockers. CONCLUSIONS: Certain aspects of JNC 7 are not well incorporated into clinical practice, especially among patients with coexisting diabetes and/or CKD.
Authors: Rany M Salem; Braj Pandey; Erin Richard; Maple M Fung; Erin P Garcia; Victoria H Brophy; Nicholas J Schork; Daniel T O'Connor; Vibha Bhatnagar Journal: Health Informatics J Date: 2010-12 Impact factor: 2.681
Authors: Elie A Akl; Reem Mustafa; Mark C Wilson; Andrew Symons; Amir Moheet; Thomas Rosenthal; Gordon H Guyatt; Holger J Schünemann Journal: Implement Sci Date: 2009-09-21 Impact factor: 7.327
Authors: Paul E Drawz; Cristina Bocirnea; Katarina B Greer; Julian Kim; Florian Rader; Patrick Murray Journal: J Gen Intern Med Date: 2009-02-07 Impact factor: 5.128
Authors: Simon de Lusignan; Hugh Gallagher; Tom Chan; Nicki Thomas; Jeremy van Vlymen; Michael Nation; Neerja Jain; Aumran Tahir; Elizabeth du Bois; Iain Crinson; Nigel Hague; Fiona Reid; Kevin Harris Journal: Implement Sci Date: 2009-07-14 Impact factor: 7.327